AD012

AD012 is a dual cACE/NEP inhibitor derived from the lenopril-tryptophan synthesis, a known C-domain selective ACE inhibitor scaffold. It is a research compound with potential applications in studying hypertension and cardiovascular protection, as suggested by its dual inhibitory mechanism in relevant in vitro and in vivo pharmacological models.